Coexpression cluster:C500
From FANTOM5_SSTAR
Full id: C500_Neutrophils_Monocytederived_blood_CD14_Eosinophils_lung_mixed
Phase1 CAGE Peaks
| Hg19::chr12:65090856..65090873,+ | p@chr12:65090856..65090873 + |
| Hg19::chr15:45007619..45007649,+ | p6@B2M |
| Hg19::chr15:45007659..45007713,+ | p3@B2M |
| Hg19::chr15:45007740..45007774,+ | p5@B2M |
| Hg19::chr15:45007776..45007836,+ | p2@B2M |
| Hg19::chr15:45009798..45009900,+ | p@chr15:45009798..45009900 + |
| Hg19::chr15:45009902..45010022,+ | p@chr15:45009902..45010022 + |
| Hg19::chr1:203276836..203276855,+ | p@chr1:203276836..203276855 + |
| Hg19::chr6:29691484..29691495,+ | p3@HLA-F |
| Hg19::chr6:30458007..30458044,+ | p@chr6:30458007..30458044 + |
| Hg19::chr6:30458081..30458117,+ | p@chr6:30458081..30458117 + |
| Hg19::chr6:30458196..30458253,+ | p@chr6:30458196..30458253 + |
| Hg19::chr6:30460680..30460737,+ | p@chr6:30460680..30460737 + |
| Hg19::chr6:31239406..31239455,+ | p@chr6:31239406..31239455 + |
| Hg19::chr6:31321862..31321941,- | p1@X07061 p1@X07062 |
| Hg19::chr6:31322867..31322902,+ | p@chr6:31322867..31322902 + |
| Hg19::chr6:31322916..31322974,- | p4@HLA-B |
| Hg19::chr6:31323216..31323285,- | p3@HLA-C p5@HLA-B |
| Hg19::chr6:31324641..31324664,- | p10@HLA-B |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
| p.value | FDR | nGenes | nPathway | Name |
|---|---|---|---|---|
| 0.000151746387523186 | 0.00800462194184805 | 2 | 204 | Endocytosis (KEGG):04144 |
| 8.87028067484744e-05 | 0.00510444333379857 | 2 | 156 | Phagosome (KEGG):04145 |
| 6.73840783266509e-05 | 0.004265412158077 | 2 | 136 | Cell adhesion molecules (CAMs) (KEGG):04514 |
| 1.96249599285332e-08 | 6.21129981738076e-06 | 3 | 78 | Antigen processing and presentation (KEGG):04612 |
| 7.28240379719336e-06 | 0.000768293600603899 | 2 | 45 | Type I diabetes mellitus (KEGG):04940 |
| 1.05241687813521e-05 | 0.000951685548370838 | 2 | 54 | Autoimmune thyroid disease (KEGG):05320 |
| 5.45153351157612e-06 | 0.000768293600603899 | 2 | 39 | Allograft rejection (KEGG):05330 |
| 6.64274556874299e-06 | 0.000768293600603899 | 2 | 43 | Graft-versus-host disease (KEGG):05332 |
| 1.87899740683929e-05 | 0.00132156150947697 | 2 | 72 | Viral myocarditis (KEGG):05416 |
| 1.48230348787841e-05 | 0.00117287263478379 | 2 | 64 | Proteasome Degradation (Wikipathways):WP183 |
| 5.70320151504265e-06 | 0.000768293600603899 | 3 | 511 | Signaling in Immune system (Reactome):REACT_6900 |
| 5.37212511845661e-09 | 3.40055519998304e-06 | 3 | 51 | {HLA-A,53} (Static Module):NA |
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
| GO ID | GO name | FDR corrected p-value |
|---|---|---|
| GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 3.44283425591547e-07 |
| GO:0048002 | antigen processing and presentation of peptide antigen | 3.44283425591547e-07 |
| GO:0042612 | MHC class I protein complex | 2.48279173867282e-06 |
| GO:0042611 | MHC protein complex | 7.44220434057843e-06 |
| GO:0019882 | antigen processing and presentation | 8.68789839607204e-06 |
| GO:0032393 | MHC class I receptor activity | 1.03087902489797e-05 |
| GO:0006955 | immune response | 0.000146634857782203 |
| GO:0002376 | immune system process | 0.000203303733848579 |
| GO:0044459 | plasma membrane part | 0.000810460688395914 |
| GO:0043234 | protein complex | 0.00146544028199587 |
| GO:0005886 | plasma membrane | 0.0029844998842909 |
| GO:0032991 | macromolecular complex | 0.0029844998842909 |
| GO:0004888 | transmembrane receptor activity | 0.0188521394295296 |
| GO:0044425 | membrane part | 0.0201582891042318 |
| GO:0004872 | receptor activity | 0.0354197492238477 |
| GO:0016020 | membrane | 0.0354197492238477 |
| GO:0004871 | signal transducer activity | 0.0442459626345693 |
| GO:0060089 | molecular transducer activity | 0.0442459626345693 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
| Ontology term | p-value | n |
|---|---|---|
| hemolymphoid system | 3.78e-29 | 108 |
| hematopoietic system | 6.19e-29 | 98 |
| blood island | 6.19e-29 | 98 |
| immune system | 2.32e-22 | 93 |
| bone marrow | 3.36e-21 | 76 |
| bone element | 1.21e-17 | 82 |
| connective tissue | 8.02e-15 | 371 |
| skeletal element | 1.36e-14 | 90 |
| lateral plate mesoderm | 1.31e-13 | 203 |
| skeletal system | 1.06e-12 | 100 |
| mesoderm | 6.15e-09 | 315 |
| mesoderm-derived structure | 6.15e-09 | 315 |
| presumptive mesoderm | 6.15e-09 | 315 |
| musculoskeletal system | 1.45e-08 | 167 |
| blood | 4.97e-08 | 15 |
| haemolymphatic fluid | 4.97e-08 | 15 |
| organism substance | 4.97e-08 | 15 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
| Motifs | -log10(p-value) |
|---|---|
|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
| TF | #promoters | Enrichment | p-value | q-value |
|---|---|---|---|---|
| CTCF#10664 | 10 | 2.82118756477633 | 0.00089703736288379 | 0.00667562242712128 |
| POLR2A#5430 | 18 | 2.03442932516028 | 1.12471092130166e-05 | 0.000287760127167623 |
| RFX5#5993 | 6 | 3.80460341911424 | 0.00343118508361132 | 0.0174608750644293 |
| WRNIP1#56897 | 2 | 11.5599962473027 | 0.0127864612829103 | 0.0460103786495957 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.
